SINCLAIR GINZA CLINIC

Over the 20 years, successfully conducted 100,000 stem cell cultivations without any incidents.
We perform treatments using products manufactured by "Ainprose" in this cultivation and processing facility.

Type: Stem Cell, Ainprose

Location: Tokyo

Director of SINCLAIR GINZA CLINIC

At SINCLAIR GINZA CLINIC, Dr. Noguchi leads the provision of Ainprose treatments through private medical care. These innovative therapies utilize cutting-edge stem cell-derived technologies to promote healing and regeneration, ensuring that patients receive the highest level of medical excellence and care.

Director of SINCLAIR GINZA CLINIC

Extensive Experience and Expertise

Dr. Noguchi serves as the Director of Sinclair Ginza Clinic, bringing an extensive career and expertise to the forefront of regenerative medicine. After graduating from Kyoto Prefectural University of Medicine in 1981, he further honed his skills as a Visiting Researcher at prestigious institutions, including the University of California, San Diego, and the University of Pittsburgh. Over the decades, he has held prominent academic and clinical positions, including as a Professor at Ryotokuji University, Director of the Orthopedic and Foot Surgery Center at Shiseikai Daini Hospital, and Visiting Professor at Tokyo Women’s Medical University.
Dr. Noguchi is dedicated to fostering open communication between patients and physicians. He believes that building a strong relationship through dialogue is key to providing personalized care tailored to each individual’s needs.

Professional history

  • 1981: Graduated from Kyoto Prefectural University of Medicine, Faculty of Medicine
  • 1990: Visiting Researcher, University of California, San Diego; Visiting Researcher, Department of Orthopedic Surgery, University of Pittsburgh
  • 1993: Lecturer (internal), Department of Orthopedic Surgery, Kyoto Prefectural University of Medicine
  • 2001: Lecturer, Department of Orthopedic Surgery, Kyoto Prefectural University of Medicine; Associate Professor, Department of Orthopedic Surgery, Tokyo Women’s Medical University; Visiting Lecturer, Department of Orthopedic Surgery, Kyoto Prefectural University of Medicine
  • 2006: Professor, Ryotokuji University; Part-time Lecturer, Department of Orthopedic Surgery, Tokyo Women’s Medical University
  • 2012: Director and Head, Orthopedic and Foot Surgery Center, Shiseikai Daini Hospital
  • 2015: Visiting Professor, Department of Orthopedic Surgery, Tokyo Women’s Medical University (present)
  • 2020: Director, Konno Clinical Medicine Research Institute, Third Kitashinagawa Hospital
  • 2022: Appointed Director, Sinclair Ginza Clinic

Certifications and Awards

  • Certified Specialist in Orthopedic Surgery (Japanese Orthopedic Association), Rheumatology, Sports Medicine, and Musculoskeletal Rehabilitation

  • Certified Specialist and Clinical Practitioner, Japanese Association of Rehabilitation Medicine

Treatments

Prices

Ainprose® 30ml 671,000 JPY (including tax)
Ainprose® 30ml×3
(+ Re:A set of 4 cosmetics + NMN supplement)
2,013,000 JPY (including tax)
Ainprose® 30ml×7
(+ Re:A set of 4 cosmetics + NMN supplement)
4,026,000 JPY (including tax)
Ainprose® 10ml 308,000 JPY (including tax)
Ainprose® 5ml 170,500 JPY (including tax)
Ainprose® 2ml Ultrasonic Penetration 86,900 JPY (including tax)
Ainprose® 1ml Ultrasonic Penetration 64,900 JPY (including tax)
Stem Cell Therapy Please ask.

※If you receive consultation without treatment, a consultation fee will be charged. ( visiting fee/¥16,600 + consultation fee per additional 15min/¥5,500)
※One of the risks associated with this therapy is that the administration of the stem cell culture supernatant may cause side effects such as temporary allergies.
※Stem cell culture supernatant is not a pharmaceutical product approved under the PMD Act.
※In Japan and other countries, there is no definitive information on the potential for serious risks associated with stem cell culture supernatant.
※There is no other approved pharmaceutical product in Japan with the same ingredients and functions as stem cell culture supernatant.

Clinic Information

Name of Medical Institution

General Incorporated Association Advalife Science
SINCLAIR GINZA

Address

FPG links GINZA 4F, 5F
2-8-19 Ginza,
Chuo-ku, Tokyo-to, Japan

Nearest Station

Ginza-itchome, Ginza, Higashi-ginza, Yurakucho(JR)

Operation Hours

10:00-13:00 / 14:00-19:00

Contact Us